Back to Trade Ideas

Wells Fargo downgrades ResMed (RMD) to Equal Weight, sets $215 target — here’s how the stock has moved on similar analyst actions

Finvera Editorial Team··analyst downgrade

How RMD has reacted before

ReportNext-day move
Aug 07, 2026+1.3%
Jul 16, 2026+1.3%
Jul 15, 2026+1.3%
Jul 13, 2026+1.3%
Jul 12, 2026+1.3%
Jul 10, 2026+1.3%
Jul 08, 2026-6.3%
Jul 01, 2026+3.2%
Jun 17, 2026-3.9%
Jun 15, 2026-1.0%
Dec 18, 2025-1.4%
Dec 16, 2025-2.3%
Aug 04, 2025+4.4%
Aug 01, 2025+2.7%

Median absolute move 1.4% · higher 9 of 14 · n=14

The call

  • Firm: wellsfargo
  • Action: Downgrades
  • Rating: Equal Weight
  • Price target: 215.00

How $RMD moves around analyst actions

DateSession move
Aug 07, 2026+1.3%
Jul 16, 2026+1.3%
Jul 15, 2026+1.3%
Jul 13, 2026+1.3%
Jul 12, 2026+1.3%
Jul 10, 2026+1.3%
Jul 08, 2026-6.3%
Jul 01, 2026+3.2%
Jun 17, 2026-3.9%
Jun 15, 2026-1.0%
Dec 18, 2025-1.4%
Dec 16, 2025-2.3%
Aug 04, 2025+4.4%
Aug 01, 2025+2.7%

Base rates (n=14):

  • Median absolute move: 1.4%
  • Finished higher: 9 of 14
  • Biggest up day: +4.4%
  • Biggest down day: -6.3%
Powered by